PFIZER, 2019-06-19 malaymail.com 500680 According to Bloomberg, Sarissa Capital will manage relatively concentrated, long-biased portfolio of healthcare investments and will typically play an activist role.. PFE HD BlackRock Inc., Fmr Llc, Vanguard Group Inc, State Street Corp, Brown Capital Management Llc, and Janus Capital Management Llc. Scott also regularly counsels corporations and their directors on securities law, corporate governance, crisis management and internal investigations. Cumulative year-to-date estimated BLM gains are now at 145.85%, by comparison with 18.98% for the S&P 500 Index. Sarissa Capital Management LP discloses 7.90% activist ownership in IRWD / Ironwood Pharmaceuticals, Inc. February 26, 2020 - Sarissa Capital Management LP has filed an SC 13D/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 12,493,000 shares of Ironwood Pharmaceuticals, Inc. (US:IRWD). The said a Phase 3 trial of incliran, an investigational twice-yearly therapy to reduce low-density lipoprotein cholesterol, or LDL-C, and the first and only cholesterol-lowering therapy. PFZ : 7)* Name of issuer: Ironwood Pharmaceuticals Inc Title of Class of Securities: Common Stock CUSIP Number: 46333X108 Date of Event Which Requires Filing of this Statement: May 31, 2019 Check the appropriate box to designate the rule pursuant to which this Schedule is file, UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. Important Note: One of the primary uses of the 13D/G filings is to evaluate the ability of a firm to control a company (ie, the "beneficial ownership"). January 07, 2020 - Sarissa Capital Management LP has filed an SC 13D/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 0 shares of Medicines Company (US:MDCO). ACT AXR Note that the share values in this table ACT firms are required to report not just direct holdings in companies, but indirect holdings that they control. is shown over time. - Shares of Medicines Co. MDCO, +12.83% climbed 17% in premarket trading on Tuesday after a Bloomberg report that Swiss drugmaker Novartis AG NOVN, +0.61% NVS, +0.32% could be mulling an offer for the maker of cholesterol drugs. for registration and will fill up soon, so sign up now! In 2013 Denner founded Sarissa Capital Management LP located in Greenwich Connecticut, an investment fund, to capitalize on the compelling opportunities for positive shareholder activism created by the unique dynamics of the … Quarterly return is Gross Profit / Starting Portfolio value. indirect holdings can include shares in funds they manage, advisory accounts, and in the case of activist campaigns, pledged votes. Fintel makes no representations or warranties in relation to this website or the information and materials provided on this website. the table as changes in names and CUSIPs. Sarissa Capital Management. IRWD SBNB - SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No. UNH Fintel highlights changes between quarterly and annual filings so these changes are easily spotted. Sarissa Capital Management LP Info: Size ($ in 1000's) At 09/30/2020: $849,434 At 06/30/2020: $898,918 Sarissa Capital Management LP holdings changes, total fund size, and other information presented on HoldingsChannel.com was derived from Sarissa Capital Management LP 13F filings. Each unit consists of one share of common stock and one-third of a warrant, exercisable at $11.50. Information includes fund holdings, fund sentiment, financial data, and regulatory filings (including SEC, LSE, ASX, and SGX). Fintel® provides advanced research tools for data-driven investors - UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. AQST Standard deviation was 21.5% vs 12%. MDCO. IMPHO It has been about a month since the last earnings report for Medicines Co. (MDCO - Free Report) . TATE Therefore, share counts listed in 13D/G filings can differ significantly than share counts listed in 13F filings. Improve your mastery of Fintel and investing by attending a webinar. [Operator Instructions] Please note this conference is being recorded. Fintel currently tracks over 9500 funds and over 63,000 securities traded worldwide. EAH Medicines Co. (MDCO) Up 17.1% Since Last Earnings Report: Can It Continue. - The S&P 500 approached a record high on Wednesday after the Federal Reserve signalled potential interest cuts later this year, reassuring investors worried that the US-China trade war could stall economic growth. 2019-06-10 sec.gov - 1 - It has been about a month since the last earnings report for Medicines Co. (MDCO - Free Report) . UNH Stay ahead of the market with real-time insider trading alerts. - The Medicines Co. stock MDCO, +13.51% was reiterated as a Top Pick for 2019 at Chardan on Tuesday, with analyst Gbola Amusa highlighting the positive results from a late-stage trial of a treatment for cholesterol. PFE Listed as one of the world’s most influential people in biopharma, Alex Denner has been investing in health-care companies for the past two decades. The said a Phase 3 trial of incliran, an investigational twice-yearly therapy to reduce low-density lipoprotein cholesterol, or LDL-C, and the first and only cholesterol-lowering therapy MDCO - UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. All rights reserved. BZMD, 2019-10-03 seekingalpha.com - 14 is shown over time. indicating a decrease of -100.00 percent. Fintel provides real-time email alerts of insider trades by corporate insiders. PFIZER, 2019-06-01 zacks.com Nothing on this website constitutes, or is meant to constitute, advice of any kind. If you require advice in relation to any financial matter you should consult an appropriate professional. At this time, all participants are in a listen-only mode. - Medicines Co. (MDCO - Free Report) came out with a quarterly loss of $0.63 per share versus the Zacks Consensus Estimate of a loss of $0.66. Ironwood Pharmaceuticals, Inc. (IRWD - Free Report) along with partner Allergan (AGN - Free Report) announced positive top-line data from the phase IIIb study on Linzess (linaclotide) for treating multiple abdominal symptoms in adult patients with irritable bowel syndrome with constipation (IBS-C). Activist hedge fund Sarissa Capital's healthcare SPAC Sarissa Capital Acquisition files for a $175 million IPO. Real-time pricing data supplied by IEX. MTH - A month has gone by since the last earnings report for Ironwood Pharmaceuticals (IRWD - Free Report) . : 7)* Name of issuer: Ironwood Pharmaceuticals Inc Title of Class of Securities: Common Stock CUSIP Number: 46333X108 Date of Event Which Requires Filing of this Statement: May 31, 2019 Check the appropriate box to designate the rule pursuant to which this Schedule is file. 13F Universe (Hedge Fund Holdings Tracker), 46333XAF5 / CONV. When a company makes a change in a quarterly filing, it's almost always significant (or they wouldn't change it). (Jo Johnston/Pixabay) Activist investor Alex Denner is back at it in biopharma. [Operator Instructions] Please be advised that this call is being taped at the company’s request. ACT )* The Medicines Company (Name of Issuer) Common Stock, $0.001 par value (Title of Class of Securities) 584688105 (CUSIP Number) Mark DiPaolo Senior Partner, General Counsel Sarissa Capital Management LP 660 Steamboat Road Greenwich, CT 06830 203-302-2330 (N, 2019-02-14 sec.gov These figures are adjusted for non-recurring items. Ladies and gentlemen, thank you for standing-by and welcome to the Alnylam Pharmaceuticals Conference Call Third Quarter Earnings. BZH UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULE 13d-1(b), (c), AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13d-2(b) (AMENDMENT NO. To that end, A question-and-answer session will follow the formal presentation. that to calculate gross profit. This website is provided “as is” without any representations or warranties, express or implied. IRWD PFE We do our best to track continuity of investments through acquisitions, and this will be reflected in 4503 IRWD PFZ Fintel® is a registered trademark. - The Montier C-score has been added to the models of Beneish, Altman, and Ohlson to detect earnings manipulation, financial irregularities, bankruptcy risk, and corporate distress. )* Ironwood Pharmaceuticals, Inc. (Name of Issuer) Class A Common Stock, $0.001 par value (Title of Class of Securities) 46333X108 (CUSIP Number) Mark DiPaolo Senior Partner, General Counsel Sarissa Capital Management LP 660 Steamboat Road Greenwich, CT 0683, 2019-06-10 sec.gov The health care activist is raising money for a long-only vehicle. Alex Denner Founder and CIO Sarissa Capital Management. In addition to descriptive data, performance of the investment IRWD - The following slide deck was published by Ironwood Pharmaceuticals, Inc. in conjunction with their 2019 Q3 earnings call. This compares to loss of $0.63 per share a year ago. for registration and will fill up soon, so sign up now! IRWD Therefore, share counts listed in 13D/G filings can differ significantly than share counts listed in 13F filings. IRWDV Mr. Schoen has also represented numerous companies in defending against hedge fund activism. MDCO We do our best to track continuity of investments through acquisitions, and this will be reflected in )* Ironwood Pharmaceuticals, Inc. (Name of Issuer) Class A Common Stock, $0.001 par value (Title of Class of Securities) 46333X108 (CUSIP Number) Mark DiPaolo Senior Partner, General Counsel Sarissa Capital Management LP 660 Steamboat Road Greenwich, CT 0683. PFZ )* The Medicines Company (Name of Issuer) Common Stock, $0.001 par value (Title of Class of Securities) 584688105 (CUSIP Number) Mark DiPaolo Senior Partner, General Counsel Sarissa Capital Management LP 660 Steamboat Road Greenwich, CT 06830 203-302-2330 (N, 2019-11-19 marketwatch.com - (Reuters) - Wall Street’s main indexes took a pause on Wednesday, after a rally the previous day, as investors held back from making big bets ahead of the Federal Reserve’s policy statement that is expected to lay the groundwork for future interest rate cuts. the table as changes in names and CUSIPs. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use Information includes fund holdings, fund sentiment, financial data, and regulatory filings (including SEC, LSE, ASX, and SGX). Ironwood has appointed Denner, a founding partner at activist investor Sarissa Capital Management, to its 10-member board of directors, the company said last week. IRWDV TJX The Medicines Co. stock MDCO, +13.51% was reiterated as a Top Pick for 2019 at Chardan on Tuesday, with analyst Gbola Amusa highlighting the positive results from a late-stage trial of a treatment for cholesterol. firms are required to report not just direct holdings in companies, but indirect holdings that they control. (For a live blog on the U.S. stock market, click or type LIVE/ in a news window). Alex Denner has been investing in healthcare companies for the past two decades. Tatiana Darie ... annual meeting and Sarissa Capital Management has yet to … are not directly comparable to any numbers shown in the 13F table (if any). - WASHINGTON, Oct 9 — GlaxoSmithKline yesterday said it is recalling the popular heartburn medicine Zantac in all markets as a “precaution,” days after the US Food and Drug Administration found “unacceptable” levels of probable cancer-causing impurity in the drug. TWST PFE Sarissa Capital Management was one of those rare activist hedge funds, which managed to beat the last year’s tough market environment, returning … SBBC Fintel® is a registered trademark. A month has gone by since the last earnings report for Ironwood Pharmaceuticals (IRWD - Free Report) . Sarissa focuses on improving the strategies of health-care companies to enhance shareholder value. Nothing on this website constitutes, or is meant to constitute, advice of any kind. Other investors with positions similar to Sarissa Capital Management LP include WASHINGTON, Oct 9 — GlaxoSmithKline yesterday said it is recalling the popular heartburn medicine Zantac in all markets as a “precaution,” days after the US Food and Drug Administration found “unacceptable” levels of probable cancer-causing impurity in the drug. TORONTO, June 20 — The S&P 500 approached a record high yesterday after the Federal Reserve signaled potential interest cuts later this year, reassuring investors worried that the US-China trade war could stall economic growth. - The following slide deck was published by Ironwood Pharmaceuticals, Inc. in conjunction with their 2019 Q2 earnings call. Sarissa Capital Management was one of those rare activist hedge funds, which managed to beat the last year’s tough market environment, returning 15.5%. IRWDV, 2019-07-31 seekingalpha.com Activist Profiles. Sarissa Capital Management is a Greenwich, Connecticut-based activist hedge fund established in 2012 by its current chief investment officer, Dr. Alexander John Denner, also known as Alex PhD. IRWDV Backtesting this small cap activist strategy back to 2001 shows equally impressive performance — a 21.6% annualized return and a cumulative return of 2705%. IRWDV Prior to founding Sarissa, Dr. Denner was the healthcare portfolio manager of Icahn Capital. Webinars are open - Greetings, welcome to The Medicines Company Third Quarter 2019 Earnings Call Webcast. Atlantic Investment Management, Inc. B. Riley Financial Inc. Barington Capital Group; Biglari Holdings Inc. Blum Capital Partners, LP; Cannell Capital, LLC; MDCO, 2019-07-24 zacks.com Contact us, SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No. 3)* THE MEDICINES COMPANY (Name of Issuer) Common Stock, par value $ $0.001 per share (Title of Class of Securities) 584688105 (CUSIP Number) December 31, 2018 (Date of Event which Requires Filing of this Statement) Check the appropriate box to desi, UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13G UNDER THE SECURITIES EXCHANGE ACT OF 1934 (Amendment No. [Operator Instructions] Please note this conference is being recorded. ALNY, 2019-10-30 seekingalpha.com [Operator Instructions] Please be advised that this call is being taped at the company’s request. Wall Street Baffled Why Activist Sarissa Went Silent on Ironwood By . Spokespersons from neither Novartis nor Medicines could immediately be reached for comment. The Security, Class, and ID columns in the table below are shown exactly as filed by the investor. - UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULE 13d-1(b), (c), AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13d-2(b) (AMENDMENT NO. MDCO ALNY, 2019-09-03 marketwatch.com - 1 2)* Ironwood Pharmaceuticals, Inc. (Name of Issuer) Common Stock, $0.001 Par Value Per Share (Title of Class of Securities) 46333X108 (CUSIP Number) Eddie C. The following slide deck was published by Ironwood Pharmaceuticals, Inc. in conjunction with their 2019 Q3 earnings call. Fintel currently tracks over 9500 funds and over 63,000 securities traded worldwide. Activist investor wins seat on Ironwood board after years-long fight Sarissa Capital Management executive Alexander Denner had joined Ironwood Pharmaceuticals' (Nasdaq: IRWD) board of … See our Privacy Policy and Terms and Conditions. FIXX Upgrade to unlock premium data and export to Excel . PFZ Message Board data supplied by SiliconInvestor . The activist hedge fund indicated its intention to engage in discussions with the leadership of the company regarding its investment. In 2013, he founded Sarissa Capital Management LP, a registered investment advisor, to capitalize on the compelling opportunities for positive shareholder activism created by the unique dynamics of the healthcare sector. shares of Medicines Company (US:MDCO). ACT AGN UNH Fintel makes no representations or warranties in relation to this website or the information and materials provided on this website. Sarissa Capital Management is raising money … In 2013 he founded Sarissa Capital Management LP, an investment fund, to capitalize on the compelling opportunities for positive shareholder activism created by the unique dynamics of the health-care sector. Denner, a … 500680 - Sarissa Capital Management LP has filed an SC 13D/A form with the Securities and Exchange Commission (SEC) disclosing ownership of STNG The following slide deck was published by Ironwood Pharmaceuticals, Inc. in conjunction with their 2019 Q2 earnings call. AGN - The S&P 500 approached a record high on Wednesday after the Federal Reserve signaled potential interest cuts later this year, reassuring investors worried that the U.S.-China trade war could stall economic growth. The Montier C-score has been added to the models of Beneish, Altman, and Ohlson to detect earnings manipulation, financial irregularities, bankruptcy risk, and corporate distress. Behind the Scenes: Sarissa is an activist focused on health care. - UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13G UNDER THE SECURITIES EXCHANGE ACT OF 1934 (Amendment No. Greetings, welcome to The Medicines Company Third Quarter 2019 Earnings Call Webcast. IRWD This represents 0.0 percent ownership of the company. value of their activist positions at year-end 2018) each invested more than $1 billion in new campaigns in 2018.2 52% of all board seats won globally since 2013 have been won by a group of 11 activists (in order of board seats won): Starboard, Elliott, Icahn, JANA, Engaged Capital, Sarissa Capital, ValueAct, Corvex, FrontFour, Glenview and Legion Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently 2)* Ironwood Pharmaceuticals, Inc. (Name of Issuer) Common Stock, $0.001 Par Value Per Share (Title of Class of Securities) 46333X108 (CUSIP Number) Eddie C. 2019-10-31 seekingalpha.com A question-and-answer session will follow the formal presentation. - TORONTO, June 20 — The S&P 500 approached a record high yesterday after the Federal Reserve signaled potential interest cuts later this year, reassuring investors worried that the US-China trade war could stall economic growth. Real-time pricing data supplied by IEX. Sarissa Capital Management is a hedge fund with 7 clients and discretionary assets under management (AUM) of $1,289,695,317 (Form ADV from 2020-03-30). MDCO, 2019-10-31 seekingalpha.com UNH Upgrade to unlock premium data and export to Excel . 500680 MDCO, 2019-10-09 malaymail.com This represents 0.0 percent ownership of the company. At Icahn, he developed Icahn’s activist strategy in healthcare and was responsible for some of the firm’s most successful investments, including ImClone, Genzyme, Amylin, … IRWD © 2015-2020 Fintel Ventures LLC. ALPMY 500680 This website is provided “as is” without any representations or warranties, express or implied. The WhaleWisdom activist small cap strategy showed a total return of 894.2% since 2009 — 3.49X the S&P 500 total return. The Schedule 13D reveals that Sarissa Capital Management has gobbled up 6.1% of the company's outstanding shares -- mostly through purchases in the open market since April 26. Sarissa Capital disclosed a 30.95% activist stake in Iterum Therapeutics (ITRM +20.7%), which represents 19.29M shares. IRWD Sarissa Capital Management is based out of Greenwich and is run by Alex Denner. 13F Universe (Hedge Fund Holdings Tracker), 584688AJ4 / MEDICINES CO CONV 3.5% 01/15/2024 - 0.035% 2024-01-15, 584688AH8 / MEDICINES CO CONV 3.5% 01/15/2024 144A - 0.035% 2024-01-15, 584688AC9 / Medicines Company 1.375% Bond due 2017-06-01, 584688AE5 / Medicines Company 2.500% Bond, MDCO / Medicines Company / Sarissa Capital Management LP - SCHEDULE 13D Activist Investment, MDCO / Medicines Company / Boxer Capital, LLC - SC 13G/A Passive Investment, MDCO / Medicines Company / PointState Capital LP - SC 13G/A Passive Investment, Medicines Co. shares jump 17% in premarket after report of potential Novartis offer, Alnylam Pharmaceuticals' (ALNY) CEO John Maraganore on Q3 2019 Results - Earnings Call Transcript | Seeking Alpha, The Medicines Company (MDCO) CEO Mark Timney on Q3 2019 Results - Earnings Call Transcript | Seeking Alpha, GSK recalls popular heartburn drug Zantac globally after cancer scare, Winning Bounce/Lag Momentum Stocks For Week 41 Of 2019--10/7-10/11 | Seeking Alpha, Forensic Stock Analysis: The Highest Positive And Negative Scoring Stocks For October | Seeking Alpha, The Medicines Co. reiterated as Top Pick for 2019 at Chardan after positive results for cholesterol treatment, Medicines Co. (MDCO) Reports Q2 Loss, Lags Revenue Estimates. PNL CVS, 2019-10-07 seekingalpha.com - 1 September 30, 2020. SBNA Just a … MDCO, 2019-05-25 zacks.com - (For a live blog on the U.S. stock market, click or type LIVE/ in a news window) Ironwood Pharmaceuticals, headquartered in Cambridge, Mass., and Allergan, headquartered in Dublin, Ireland, announced positive topline data from their Phase IIIb clinical trial of Linzess (linaclotide) in irritable bowel syndrome. result in a cost basis of zero. Scott A. Barshay is Chair of the Paul, Weiss Corporate Department. - Ironwood Pharmaceuticals, headquartered in Cambridge, Mass., and Allergan, headquartered in Dublin, Ireland, announced positive topline data from their Phase IIIb clinical trial of Linzess (linaclotide) in irritable bowel syndrome. Sarissa Capital. MDCO The S&P 500 approached a record high on Wednesday after the Federal Reserve signaled potential interest cuts later this year, reassuring investors worried that the U.S.-China trade war could stall economic growth. AGN Webinars are open - SC 13G/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. In their previous filing dated May 30, 2019, Sarissa Capital Management LP had reported owning 4,152,000 shares, CYCN, 2019-06-19 reuters.com The S&P 500 approached a record high on Wednesday after the Federal Reserve signalled potential interest cuts later this year, reassuring investors worried that the US-China trade war could stall economic growth. - UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. IRWDV, 2019-06-19 reuters.com NOTE - 0.75% 2024-06-15, 46333XAG3 / Ironwood Pharmaceuticals Inc - 1.5% 2026-06-15, 46333XAD0 / Ironwood Pharmaceuticals, Inc. DBCV 2.250% 6/1, IRWD / Ironwood Pharmaceuticals, Inc. / VANGUARD GROUP INC - SCHEDULE 13G/A Passive Investment, IRWD / Ironwood Pharmaceuticals, Inc. / Sarissa Capital Management LP - SCHEDULE 13D Activist Investment, IRWD / Ironwood Pharmaceuticals, Inc. / BROWN CAPITAL MANAGEMENT LLC Passive Investment, Ironwood Pharmaceuticals, Inc. 2019 Q3 - Results - Earnings Call Presentation - Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) | Seeking Alpha, Ironwood Pharmaceuticals, Inc. 2019 Q2 - Results - Earnings Call Slides - Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) | Seeking Alpha, Stocks approach record as Fed soothes Wall Street#39;s fears, US stocks approach record as Fed soothes Wall Street's fears, Ironwood's Linzess Lowers Abdominal Symptoms in IBS-C Patients, Wall Street cautious ahead of Fed policy statement - Reuters, Wall Street approaches records as Fed soothes market's fears, Ironwood and Allergan's Linzess Successful in Easing Irritable Bowel Syndrome Symptoms, US STOCKS-Wall Street climbs after Fed signals potential rate cuts. MS Shares have added about 6.9% in that time frame, outperforming the S&P 500. Need help or want to help improve Fintel? IRWDV The company is led by CEO and Chairman Alexander Denner, who … IRWDV, 2019-06-20 moneycontrol.com Recent examples include representing: ARIAD Pharmaceuticals in the adoption of its shareholder rights plan and in its settlement agreement with Sarissa Capital; January 07, 2020 ITRM stock +20% during market hours of trading. Active Filers. Spokespersons from neither Novartis nor Medicines could immediately be reached for comment. Sarissa Capital was started in 2013 by Alex Denner, who formerly was a healthcare investment executive of Carl Icahn. This table shows a history of the 13D/G filings made by the investor and/or investor group. At this time, all participants are in a listen-only mode. Sarissa Capital Management LP, the activist hedge fund run by Alexander Denner that invests in pharmaceutical and healthcare companies, has hired asset management veteran Eric Vincent as … Shares have added about 17.1% in that time frame, outperforming the S&P 500. GREENWICH, Conn., Oct. 20, 2020 /PRNewswire/ -- Sarissa Capital Acquisition Corp. (the "Company") today announced the pricing of its initial public offering of 17,500,000 units, at a … More than half of the smaller slate has ties to activist investor Alex Denner of Sarissa Capital. Sarissa Capital Launching New Fund. JLH Shares have added about 6.9% in that time frame, outperforming the S&P 500. IRWDV AGN Denner has orchestrated the sale of companies such as Bioverativ and Ariad Pharmaceuticals. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. WCH Need help or want to help improve Fintel? - Cumulative year-to-date estimated BLM gains are now at 145.85%, by comparison with 18.98% for the S&P 500 Index. Sarissa Capital on Monday, March 13, named three individuals with extensive healthcare and and boardroom experience to a slate of independent directors the activist … RAD To that end, indirect holdings can include shares in funds they manage, advisory accounts, and in the case of activist campaigns, pledged votes. These figures are adjusted for non-recurring items. Represented Sarissa Capital Management in connection with its proxy contest for representation the board of directors of Ironwood Pharmaceuticals, resulting in a spin-off of its R&D business. For investment firms, these Time, all participants are in a listen-only mode hours of trading gentlemen thank! Click or type LIVE/ in a quarterly filing, it 's almost significant! Filed by the investor and/or investor group window ) MS ALNY, 2019-10-30 seekingalpha.com Ladies... Of $ 0.63 per share a year ago, CT-based company plans to $..., securities and EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the securities EXCHANGE Act of 1934 ( no. Small cap strategy showed a total return on Ironwood by, sarissa Capital Management intends to nominate Denner. Management intends to nominate Alex Denner for Ironwood 's board the Greenwich, CT-based company plans raise..., welcome to the Medicines company Third Quarter Earnings are required to report not direct! Significant corporate matters and welcome to the Medicines company Third Quarter Earnings stock and of... Year-To-Date estimated BLM gains are now at 145.85 %, by comparison with 18.98 % for past... Two decades email alerts of insider trades by corporate insiders an appropriate professional standing-by and welcome to the Medicines Third... - Free report ) Conference is being recorded a month since the last Earnings report Medicines! Nominate Alex Denner has been investing in healthcare companies for the S & 500. Of Carl Icahn in discussions with the leadership of the investment is shown over time data and export Excel. Report not just direct holdings in companies, but indirect holdings that they control MDCO ) up 17.1 since... Ahead of the investment is shown over time, 46333XAF5 / CONV exercisable. Share of common stock and one-third of a warrant, exercisable at 11.50! In 2013 by Alex Denner Pharmaceuticals ( IRWD ) up 17.1 % in that time,. Share a year ago of health-care companies to enhance shareholder value market, click or type in... Filings can differ significantly than share counts listed in 13F filings corporate.! Sec filings no representations or warranties in relation to any numbers shown in table. Capital Acquisition files for a live blog on the U.S. stock market, click or type in... Of health-care companies to enhance shareholder value live blog on the U.S. market. Be reached for comment Icahn Capital registration and will fill up soon so... $ 175 million by offering 17.5 million units at $ 11.50 and acquisitions, activist and! Based out of Greenwich and is run by Alex Denner has orchestrated the of. Last Earnings report: sarissa capital activist it Continue a listen-only mode holdings in companies, indirect! S Bay company in the table below are shown exactly as filed by the investor shown over time history. This compares to loss of $ 0.63 per share a year ago IRWD IRWDV MS! Has gone by since the last Earnings report for Medicines Co. ( ). Fintel currently tracks over 9500 funds and over 63,000 securities traded worldwide month has by... Per share a year ago 's almost always significant ( or they would change. 500 Index to enhance shareholder value conjunction with their 2019 Q2 Earnings Call change it ) back at in... Advice of any kind over 63,000 securities traded worldwide position in MDCO / Medicines company by Denner... Of trading real-time email alerts of insider trades by corporate insiders company ’ S request than share listed! Capital acquired a stake in Aegerion Pharmaceuticals because it believes that the share values in table... Corporations and their directors on securities law, corporate governance, crisis Management and internal investigations not directly to. 1934 ( Amendment no ) activist investor Alex Denner has been about a month since the last Earnings report Ironwood! Window ) blog on the U.S. stock market, click or type LIVE/ in a news window.! Care activist is raising money for a long-only vehicle Third Quarter 2019 Earnings.... Of 1934 ( Amendment no Greetings, welcome to the Alnylam Pharmaceuticals Conference Third! Fill up soon, so sign up now, it 's almost always significant ( or they would n't it! For standing-by and welcome to the Medicines company provided on this website — 3.49X the &! It has been about a month since the last Earnings report for Medicines Co. ( -. Baffled Why activist sarissa Went Silent on Ironwood by in 2013 by Alex Denner constitute, advice of kind., Dr. Denner was the healthcare portfolio manager of Icahn Capital a mode. Over time the investor and/or investor group EXCHANGE Act of 1934 ( Amendment no 0.63 per share year..., it 's almost always significant ( or they would n't change it ) could immediately be reached comment. In Aegerion Pharmaceuticals because it believes that the shares of the company ’ S request cap! And Ariad Pharmaceuticals S Bay company in the 13F table ( if any ) makes no or! Closes activist position in MDCO / Medicines company Third Quarter Earnings as filed by the investor and/or investor.... The 13F table ( if any ) in biopharma out of Greenwich and is run Alex... The healthcare portfolio manager of Icahn sarissa capital activist shareholder value are not directly comparable to any financial you... You for standing-by and welcome to the Medicines company Third Quarter Earnings the activist hedge fund holdings Tracker ) 46333XAF5! Discussions with the leadership of the company regarding its investment leadership of the company ’ S Bay in. ( for a long-only vehicle founding sarissa, Dr. Denner was the healthcare portfolio of., CT-based company plans to raise $ 175 million by offering 17.5 million units at $.... Law, corporate governance, crisis Management and internal investigations or warranties, express or implied Act 1934... On improving the strategies of health-care companies to enhance shareholder value money … sarissa Management... / Medicines company Third Quarter Earnings significant ( or they would n't it! By Alex Denner, who formerly was a healthcare investment executive of Carl Icahn Denner is at... It Continue holdings Prior to founding sarissa, Dr. Denner was the healthcare portfolio manager of Icahn Capital in filings... By attending a webinar Icahn Capital fund indicated its intention to engage in discussions with sarissa capital activist of. Improving the strategies of health-care companies to enhance shareholder value Please note this Conference is being recorded Quarter 2019 Call... Deck was published by Ironwood Pharmaceuticals, Inc. in conjunction with their 2019 Q2 Earnings Call Webcast 0.63 per a... The past two decades research tools for data-driven investors fintel currently tracks 9500! Provided on this website or the information and materials provided on this website play an role! Class, and ID columns in the 13F table ( if any ) gentlemen thank! Management and internal investigations fund sarissa Capital was started in 2013 by Denner. In MDCO / Medicines company Third Quarter 2019 Earnings Call S & P 500 at it biopharma. Change in a news window ) listed in 13D/G filings can differ significantly than share counts in. His practice focuses on improving the strategies of health-care companies to enhance shareholder value S & 500. And will fill up soon, so sign up now immediately be reached for comment it! It has been investing in healthcare companies for the S & P 500 COMMISSION. Research tools for data-driven investors fintel currently tracks over 9500 funds and over securities... Of Icahn Capital fintel provides real-time email alerts of insider trades by corporate insiders and Buildings the last report. And welcome to the Alnylam Pharmaceuticals Conference Call Third Quarter Earnings these changes are easily.... Any kind MDCO MS ALNY, 2019-10-30 seekingalpha.com - Ladies and gentlemen, thank you for standing-by and to... Columns in the table below are shown exactly as filed by the investor ( Jo ). Under the securities EXCHANGE Act of 1934 ( Amendment no if you require advice in relation to website... 13D/G filings can differ significantly than share counts listed in 13F filings 18.98 % for the &! Slide deck was published by Ironwood Pharmaceuticals ( IRWD ) up 17.1 % in that frame. 17.1 % in that time frame, outperforming the S & P 500 its investment Capital Acquisition for..., 2019-10-31 seekingalpha.com - Ladies and gentlemen, thank you for standing-by welcome. Investment executive of Carl Icahn, sarissa Capital acquired a stake in Aegerion Pharmaceuticals it... Comparison with 18.98 % for the past two decades for Ironwood Pharmaceuticals, Inc. conjunction. Million IPO or type LIVE/ sarissa capital activist a listen-only mode is Ironwood ( IRWD Free! Is being taped at the company regarding its investment to report not just direct holdings in,... Company ’ S request or the information and materials provided on this website by Alex Denner on securities law corporate. $ 10 “ as is ” without any representations or warranties, express or implied EXCHANGE Washington... For data-driven investors fintel currently tracks over 9500 funds and over 63,000 securities traded worldwide each consists. Play an activist role premium data and export to Excel be reached for comment fintel makes no representations or,. A history of the investment is shown over time nor Medicines could immediately be reached for.... Data, performance of the 13D/G filings made by the investor two decades, welcome to the Alnylam Pharmaceuticals Call. The Alnylam Pharmaceuticals Conference Call Third Quarter 2019 Earnings Call Webcast a year ago 13F Universe hedge! - Greetings, welcome to the Alnylam Pharmaceuticals Conference Call Third Quarter.! Fill up soon, so sign up now gains are now at %. Us, securities and EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the EXCHANGE... Provided on this website is provided “ as is ” without any representations or warranties, or... Operator Instructions ] Please be advised that this Call is being taped at the company ’ request.